arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain … – MarketWatch (press release)

by admin on September 12, 2013

arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain
MarketWatch (press release)
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody(TM) technology. Nav1.7 has been thoroughly validated as a 

and more »

View full post on chronic pain – Google News

Previous post:

Next post: